Procter & Gamble Company (The) $PG Shares Sold by Lakeside Advisors INC.

Lakeside Advisors INC. decreased its position in Procter & Gamble Company (The) (NYSE:PG) by 3.3% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 36,907 shares of the company’s stock after selling 1,245 shares during the period. Procter & Gamble makes up about 3.8% of Lakeside Advisors INC.’s investment portfolio, making the stock its 5th largest position. Lakeside Advisors INC.’s holdings in Procter & Gamble were worth $5,880,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of PG. Kingstone Capital Partners Texas LLC lifted its holdings in shares of Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Procter & Gamble during the first quarter valued at $1,954,941,000. Price T Rowe Associates Inc. MD lifted its holdings in shares of Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Invesco Ltd. lifted its holdings in shares of Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after purchasing an additional 2,228,151 shares during the last quarter. Finally, Valeo Financial Advisors LLC lifted its holdings in shares of Procter & Gamble by 1,875.5% during the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after purchasing an additional 1,674,139 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Stock Performance

Shares of NYSE PG opened at $152.60 on Wednesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The firm has a market cap of $357.16 billion, a price-to-earnings ratio of 23.44, a P/E/G ratio of 4.13 and a beta of 0.36. The business’s 50-day simple moving average is $155.30 and its 200-day simple moving average is $159.79. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43.

Procter & Gamble (NYSE:PG) last announced its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the prior year, the company earned $1.40 EPS. The firm’s revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Insider Activity

In other Procter & Gamble news, CFO Andre Schulten sold 4,252 shares of the firm’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $647,281.96. Following the completion of the sale, the chief financial officer owned 53,992 shares in the company, valued at approximately $8,219,202.16. This trade represents a 7.30% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Balaji Purushothaman sold 490 shares of the firm’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $74,592.70. Following the completion of the sale, the insider owned 12,616 shares of the company’s stock, valued at $1,920,533.68. This represents a 3.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock worth $23,421,279 over the last 90 days. Company insiders own 0.20% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on PG. Evercore ISI reissued an “in-line” rating and issued a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Weiss Ratings reissued a “hold (c+)” rating on shares of Procter & Gamble in a research note on Saturday, September 27th. BNP Paribas reaffirmed an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. Berenberg Bank upped their target price on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research report on Wednesday, September 17th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus price target of $173.11.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.